West Pharmaceutical ServicesWST
紐約證券 · USD
237.40
-1.86
(-0.78%)
盤中 08/01 09:43 (UTC+8)
08/01 09:43 (UTC+8)
West Pharmaceutical ServicesWST
237.40
-1.86
(-0.78%)
財務數據
損益表
- 7.17
- 7.54
- 7.47
- 7.32
- 6.95
- 7.02
- 7.47
- 7.49
- 6.98
- 7.67
- 1.11
- 5.19
- -0.85
- -2.06
- -5.00
- 0.96
- 6.38
- 0.25
- -6.78
- 9.81
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 766,500 | 698,000 | 748,800 | 746,900 | 702,100 | 695,400 | 732,000 | 747,400 | 753,800 | 716,600 |
營業成本 | 492,600 | 466,100 | 475,200 | 482,200 | 472,100 | 465,200 | 453,800 | 459,100 | 462,400 | 445,300 |
營業毛利 | 273,900 | 231,900 | 273,600 | 264,700 | 230,000 | 230,200 | 278,200 | 288,300 | 291,400 | 271,300 |
營業費用 | 115,000 | - | 114,000 | 103,400 | 103,800 | - | 117,300 | 111,000 | 108,900 | 116,000 |
研發費用 | 19,100 | 16,300 | 18,500 | 15,500 | 17,500 | 17,600 | 18,400 | 16,400 | 16,500 | 17,100 |
推銷及管理費用 | 95,900 | 108,600 | 95,500 | 87,900 | 86,300 | 89,800 | 98,900 | 94,600 | 92,400 | 98,900 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 158,900 | 107,000 | 159,600 | 161,300 | 126,200 | 122,800 | 160,900 | 177,300 | 182,500 | 155,300 |
其他收入及費用 | - | 3,900 | 4,500 | 3,900 | 4,000 | 6,200 | 8,500 | 12,600 | 5,100 | 4,800 |
利息費用 | 100 | 400 | -800 | 700 | 1,500 | 1,600 | 1,200 | 2,900 | 2,700 | 2,200 |
稅前純益 | 157,000 | 110,500 | 164,900 | 164,500 | 128,700 | 127,400 | 168,200 | 187,000 | 184,900 | 157,900 |
所得稅 | 30,200 | 24,100 | 36,800 | 32,400 | 21,900 | 16,400 | 34,500 | 29,400 | 34,800 | 23,600 |
稅後純益 | 131,800 | 89,800 | 130,100 | 136,000 | 111,300 | 115,300 | 137,000 | 161,300 | 155,100 | 140,000 |
基本每股稅後盈餘(元) | 1.82 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 | 2.08 | 1.88 |
稀釋每股稅後盈餘(元) | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 | 2.06 | 1.85 |
基本平均股數(千股) | 72200.00 | 72500.00 | 72700.00 | 72800.00 | 73000.00 | 73500.00 | 74100.00 | 74300.00 | 74300.00 | 74500.00 |
稀釋平均股數(千股) | 72500.00 | 73000.00 | 73300.00 | 73400.00 | 73700.00 | 74300.00 | 75000.00 | 75300.00 | 75400.00 | 75700.00 |
還原基本每股稅後盈餘(元) | 1.82 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 | 2.17 | 2.08 | 1.88 |
還原稀釋每股稅後盈餘(元) | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.83 | 2.14 | 2.06 | 1.85 |
還原基本平均股數(千股) | 72,200 | 72,500 | 72,700 | 72,800 | 73,000 | 73,500 | 74,100 | 74,300 | 74,300 | 74,500 |
還原稀釋平均股數(千股) | 72,500 | 73,000 | 73,300 | 73,400 | 73,700 | 74,300 | 75,000 | 75,300 | 75,400 | 75,700 |
EBITDA(千元) | 203,500 | 154,300 | 206,800 | 209,300 | 173,600 | 168,900 | 208,600 | 229,300 | 226,700 | 197,400 |